Allogene Therapeutics Inc (ALLO) stock news · $258.1M cap
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
This ALLO news page leads with what Allogene Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for ALLO yet. We will not pad this page with generic market recap.
Latest reported ALLO revenue for 2025-12-31 was $0. Net income was -$190.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ALLO currently screens at market cap $258.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ALLO stock page; for the tape open the quote page.
ALLO stock news FAQ
What is ALLO's latest net income?
Latest cached Allogene Therapeutics Inc (ALLO) net income was -$190.9M. Statements: https://lician.com/financials/allo
What is ALLO's market cap?
Allogene Therapeutics Inc (ALLO) market cap is $258.1M on the latest cached fundamentals snapshot.
What kind of company is ALLO?
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Where is ALLO stock news listed?
Cached stock news for Allogene Therapeutics Inc (ALLO) is listed at https://lician.com/news/allo. Filings: https://lician.com/sec/allo
Not investment advice.